Literature DB >> 23824735

Antibiotic prophylaxis for short-term catheter bladder drainage in adults.

Gail Lusardi1, Allyson Lipp, Christine Shaw.   

Abstract

BACKGROUND: Urinary tract infections account for about 40% of hospital-acquired (nosocomial) infections, and about 80% of urinary tract infections acquired in hospital are associated with urinary catheters.
OBJECTIVES: To determine if certain antibiotic prophylaxes are better than others in terms of prevention of urinary tract infections, complications, quality of life and cost-effectiveness in short-term catheterisation in adults. SEARCH
METHODS: We searched the Cochrane Incontinence Group Specialised Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and MEDLINE in Process, and handsearching of journals and conference proceedings (searched 31st October 2012). Additionally, we examined all reference lists of identified trials. SELECTION CRITERIA: All randomised and quasi-randomised trials comparing antibiotic prophylaxis for short-term (up to and including 14 days) catheterisation in adults. DATA COLLECTION AND ANALYSIS: Data were independently extracted by all review authors and compared. Disagreements were resolved by discussion. Data were processed as described in the Cochrane Handbook for Systemtic Reviews of Interventions. Where data had not been fully reported, clarification was sought directly from the authors of the trial. MAIN
RESULTS: Six parallel-group randomised controlled trials with 789 participants met the inclusion criteria. All six trials compared antibiotic prophylaxis versus no prophylaxis. Studies presented a low to unclear risk of bias with similar interventions and measured outcomes.The primary outcome of bacteriuria was less common in the prophylaxis group amongst surgical patients with asymptomatic bacteriuria (I(2) = 0; risk ratio (RR) 0.20; 95% confidence interval (CI) 0.13 to 0.31) . Two non-surgical studies could not be combined in a meta-analysis due to heterogeneity and only one showed significantly fewer cases of bacteriuria (RR 0.19; 95% CI 0.09 to 0.37).Two trials of surgical patients with asymptomatic bacteriuria only (255 participants) compared one type of antibiotic prophylaxis with another and neither study showed a significant difference in cases of bacteriuria.One study (78 participants) compared antibiotic prophylaxis in patients at catheterisation only versus antibiotic prophylaxis throughout catheterisation period with asymptomatic bacteriuria. Antibiotics at catheterisation only, resulted in significantly fewer cases of bacteriuria than giving prophylaxis throughout the catheterisation period (RR 0.29 95% CI 0.09 to 0.91).Secondary data of pyuria were provided by two surgical studies (255 participants). When studies were pooled, pyuria occurred in significantly fewer cases in the prophylactic antibiotic group (RR 0.23, 95% CI 0.13 to 0.42). The number of gram-negative isolates in patients' urine just before catheter removal in one study (RR 0.05, 95% CI 0.00 to 0.79) and six weeks after hospital discharge (RR 0.36, 95% CI 0.23 to 0.56) were significantly lower. There were no events in the treatment group before catheter removal. When pooled data from two studies showed significantly reduced febrile morbidity in those receiving antibiotic prophylaxis (RR 0.53 95% CI 0.31 to 0.89).Although all studies assessed micro-organisms isolated from the urine specimens the data were too heterogenous to pool in a meta-analysis and have been provided in a narrative form. Further secondary data such as economic analysis, length of stay and quality of life were not covered in detail. AUTHORS'
CONCLUSIONS: The limited evidence indicated that receiving prophylactic antibiotics reduced the rate of bacteriuria and other signs of infection, such as pyuria, febrile morbidity and gram-negative isolates in patients' urine, in surgical patients who undergo bladder drainage for at least 24 hours postoperatively. There was also limited evidence that prophylactic antibiotics reduced bacteriuria in non-surgical patients.

Entities:  

Mesh:

Year:  2013        PMID: 23824735     DOI: 10.1002/14651858.CD005428.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  10 in total

Review 1.  Catheter-Associated Urinary Tract Infections in Adult Patients.

Authors:  Jennifer Kranz; Stefanie Schmidt; Florian Wagenlehner; Laila Schneidewind
Journal:  Dtsch Arztebl Int       Date:  2020-02-07       Impact factor: 5.594

2.  Propofol Sedation Exacerbates Kidney Pathology and Dissemination of Bacteria during Staphylococcus aureus Bloodstream Infections.

Authors:  Lavanya Visvabharathy; Nancy E Freitag
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

3.  [Superficial bladder cancer: Transurethral resection and instillation therapy].

Authors:  M Schenck; G Lümmen
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

4.  Cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections.

Authors:  Rui Wang; Michele R Hacker; Roger Lefevre
Journal:  Int Urogynecol J       Date:  2019-07-01       Impact factor: 2.894

5.  Prophylactic antibiotic use in pediatric patients undergoing urinary tract catheterization: a survey of members of the Society for Pediatric Urology.

Authors:  Alexander P Glaser; Ilina Rosoklija; Emilie K Johnson; Elizabeth B Yerkes
Journal:  BMC Urol       Date:  2017-09-06       Impact factor: 2.264

Review 6.  A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence.

Authors:  Cara L Grimes; Ethan M Balk; Catrina C Crisp; Danielle D Antosh; Miles Murphy; Gabriela E Halder; Peter C Jeppson; Emily E Weber LeBrun; Sonali Raman; Shunaha Kim-Fine; Cheryl Iglesia; Alexis A Dieter; Ladin Yurteri-Kaplan; Gaelen Adam; Kate V Meriwether
Journal:  Int Urogynecol J       Date:  2020-04-27       Impact factor: 2.894

Review 7.  Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects.

Authors:  Glenn T Werneburg
Journal:  Res Rep Urol       Date:  2022-04-04

Review 8.  Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases.

Authors:  Justin Loloi; Mustufa Babar; Kelvin P Davies; Sylvia O Suadicani
Journal:  Ther Adv Urol       Date:  2022-07-26

9.  Strategies for the removal of short-term indwelling urethral catheters in adults.

Authors:  Awaiss Ellahi; Fiona Stewart; Emily A Kidd; Rhonda Griffiths; Ritin Fernandez; Muhammad Imran Omar
Journal:  Cochrane Database Syst Rev       Date:  2021-06-29

Review 10.  Urinary tract infection in women.

Authors:  Krzysztof Czajkowski; Magdalena Broś-Konopielko; Justyna Teliga-Czajkowska
Journal:  Prz Menopauzalny       Date:  2021-04-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.